The webinar includes discussion of the latest European biotech patent case law developments including:

• T1437/21: novelty and inventive step of treating a patient subpopulation in view of prior art of a phase 3 clinical trial.
• T1941/21: inventive step over clinical trial protocol and novelty over combination therapy.
• T0197/22: insufficieny of a first medical claim.

System requirements

To view our webinars we recommend the following internet browsers:

• Google Chrome (most recent 2 versions).
• Mozilla Firefox (most recent 2 versions).
• Apple Safari (most recent 2 versions).
• Microsoft Edge (most recent 2 versions).